Multiple Sclerosis Resource Centre
  • Home
  • About MS
  • MSRC Services
  • Get Involved
  • MS Research News
  • MSRC Groups
  • Useful Resources
  • Welcome To Josephs Court, MS Centre Of Excellence
  • Advertising
  • E-Newsletter
  • Contact Us
  • Cookie Policy
  • Investor in People
    You are here : Home » Get Involved » MSRC Interactive » Gilenya® User Diaries

    Gilenya® User Diaries

    A A A
    [Print this page]

    Share |


    GilenyaTo aid those who may have been prescribed Gilenya® or those thinking of asking their Neurologist to prescribe Gilenya® we at the MSRC have enlisted the help of people with MS who are now currently taking Gilenya® to provide some insight into how they went about getting the drug and how the drug has changed, or not, their condition.

    If you are currently taking Gilenya®, and would like to join our panel of "Diarists" please contact the MSRC Webmaster at [email protected]


    Gilenya® (fingolimod) is the first in a new class of disease-modifying treatments called sphingosine 1-phosphate receptor (S1P-R) modulators and has a novel mode of action different from all currently marketed MS therapies.


    Gilenya® Diarists

    © Multiple Sclerosis Resource Centre

    Related Items
    Debbie's Gilenya Diary
    Kim's Gilenya Diary
    Liz's Gilenya Diary
    Mike's Gilenya Diary
    Toots Mstruth
    Have Your Say
    Help, Advice and Inspiration from people with MS
    Stella's Haematopoietic Stem Cell Transplantation (HSCT) Blog
    Tysabri® User Diaries


    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.